Document is current
Any future updates will be listed below
-
Authors
Kalinski, Jarmo-Charles J.
Pakkir Mohamed Shah, Abzer K.
Ruiz Brandão da Costa, Bruno
Farrell, Shane P.
Schellenberg, Lisa https://orcid.org/0000-0003-0455-4396
Graves, Lana G.
Schramm, Tilman
Stincone, Paolo
Koester, Irina https://orcid.org/0000-0002-1571-882X
Stephens, Brandon M.
Torres, Ralph R. https://orcid.org/0000-0002-5816-6068
Cancelada, Lucia
Utermann-Thüsing, Caroline
Quinlan, Zachary A. https://orcid.org/0000-0002-0351-8927
Wegley Kelly, Linda
Carlson, Craig A. https://orcid.org/0000-0003-2591-5293
Castillo-Ilabaca, Cristóbal
Pantoja-Gutiérrez, Silvio
Beman, J. Michael https://orcid.org/0000-0002-0655-4800
Hartmann, Aaron
Aron, Allegra
Siwe Noundou, Xavier https://orcid.org/0000-0002-8667-8351
Dorrington, Rosemary A. https://orcid.org/0000-0002-8694-367X
Tasdemir, Deniz
Haas, Andreas F.
Dorrestein, Pieter C.
Nelson, Craig E.
Aluwihare, Lihini I. https://orcid.org/0000-0001-5031-9464
Wang, Mingxun
Petras, Daniel https://orcid.org/0000-0002-6561-3022
-
Funding
Funding for this research was provided by:
Simons Foundation (SFI-LS-ECIAMEE-00013858)
Deutsche Forschungsgemeinschaft (EXC 2124)
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 21 January 2026
First Online: 16 March 2026
Competing interests
: P.C.D. is an advisor and holds equity in Cybele, BileOmix and Sirenas and is a scientific co-founder, advisor, holds equity in and/or received income from Ometa, Enveda and Arome with prior approval by UC-San Diego. P.C.D. also consulted for DSM animal health in 2023. M.W. is a co-founder of Ometa Labs LLC. The remaining authors declare no competing interests.
